Negli ultimi anni, per, si verificato un punto di svolta nel trattamento farmacologico dellobesit: grazie a risultati incoraggianti negli studi clinici, nel 2021 stato approvato dallEMA un analogo del GLP-1 , chiamato semaglutide
Trulicity (Dulaglutide) offers multiple benefits, especially for people with type 2 diabetes, and a risk reduction of cardiovascular events (heart attack or stroke) in people with type 2 diabetes
This, combined with lifestyle changes, promotes weight loss
The compliance of the patients in the placebo and L-carnitine groups was 90.5% 11.5% and 85.1% 17.2%, respectively, which was not significantly different
82,105,106,107 ) (Fig
Laboratory research record on GLP-1S [PMID: 41575765] PubMed laboratory record discussing GLP-1S in a research context